Edgar Snyder & Associates®
A Law Firm Representing Injured People
1-866-943-3427
Call Us Toll Free 24/7
Published on Nov 14, 2006 by Edgar Snyder

Suspicious Behavior Linked to Tamiflu

Tamiflu

The Food and Drug Administration (FDA) is suggesting a revision to Tamiflu’s U.S. label that will include a warning for close supervision of all patients, especially children. This suggested label change comes after 103 reports from Japan of odd behavior mostly in children and included three deaths from falls.

The FDA wants the U.S. label to look more like that of Japan’s warning of disturbances in consciousness, abnormal behavior, delirium, hallucination, delusion and convulsions may occur. The label will warn not to stop use before seeking a doctor’s advice. Currently, the U.S. label only warns of seizures and confusion.

Tamiflu is more commonly prescribed in Japan where prescriptions are 10 times higher than the U.S. which has more than twice the population.

Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries
Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Ohio, and West Virginia and we associate with experienced attorneys in other states. In addition, all drug-related litigation involves co-counsel.

Source: “FDA Warns About ‘Bizarre’ Behavior, Tamiflu.” The Associated Press. November 13, 2006.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
ZIP
Phone
Email
Briefly describe your injuries

Recent News

Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Tweet